SCHEMBL6479916

SCHEMBL6479916

Nc1ccccc1C=Cc1nc2ccccc2[nH]1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 11/20 0.61
▸ ALDH1A1 P00352 10/20 0.61
▸ NPC1 O15118 10/20 0.61
▸ KDM4E B2RXH2 9/20 0.61
▸ SMN1; SMN2 Q16637 7/20 0.61
▸ MEN1 O00255 7/20 0.61
▸ KMT2A Q03164 7/20 0.61
▸ HPGD P15428 5/20 0.61
▸ PKM P14618 3/20 0.61
▸ HSP90AA1 P07900 1/20 0.61
▸ MAPT P10636 7/20 0.58
▸ LMNA P02545 5/20 0.58
▸ GAA P10253 5/20 0.58
▸ HTT P42858 3/20 0.58
▸ GLA P06280 3/20 0.58
▸ ALPL P05186 1/20 0.58
▸ ALPG P10696 1/20 0.58
▸ NFKB1 P19838 2/20 0.55
▸ NFKB2 Q00653 2/20 0.55
▸ RELA Q04206 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1086983 0.84 ALDH1A1 (0.81) RAB9AALDH1A1NPC1KDM4ESMN1; SMN2
SCHEMBL29539476 0.84 ALDH1A1 (0.81) RAB9AALDH1A1NPC1KDM4ESMN1; SMN2
SCHEMBL1086985 0.84 ALDH1A1 (0.81) RAB9AALDH1A1NPC1KDM4ESMN1; SMN2
SCHEMBL31305038 0.78 NPC1 (0.89) RAB9AALDH1A1NPC1KDM4ESMN1; SMN2
SCHEMBL6481418 0.77 NPC1 (0.76) RAB9AALDH1A1NPC1KDM4ESMN1; SMN2
SCHEMBL6481416 0.77 NPC1 (0.76) RAB9AALDH1A1NPC1KDM4ESMN1; SMN2
SCHEMBL17609266 0.77 NPC1 (0.65) RAB9AALDH1A1NPC1KDM4ESMN1; SMN2
SCHEMBL29660212 0.76 NPC1 (1.00) RAB9AALDH1A1NPC1KDM4ESMN1; SMN2
SCHEMBL537904 0.76 NPC1 (1.00) RAB9AALDH1A1NPC1KDM4ESMN1; SMN2
SCHEMBL537905 0.76 NPC1 (1.00) RAB9AALDH1A1NPC1KDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050260126-A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein BF RESEARCH INSTITUTE (JP) 2005-11-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050260126-A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein PRNP, PRPH, PCNP RAB9A 1787/4885ALDH1A1 1577/4885NPC1 147/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback